BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 4744597)

  • 21. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 22. Intensive chemotherapy for Hodgkin's disease: long-term complications.
    DeVita VT; Arseneau JC; Sherins RJ; Canellos GP; Young RC
    Natl Cancer Inst Monogr; 1973 May; 36():447-54. PubMed ID: 4744600
    [No Abstract]   [Full Text] [Related]  

  • 23. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    Kaplan HS; Rosenberg SA
    Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
    [No Abstract]   [Full Text] [Related]  

  • 24. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F; Coltman CA
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Fairley GH
    Ser Haematol; 1973; 6(2):196-201. PubMed ID: 4784374
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM; Asselain B; Bayle C; Teillet F; Clot P; Dana M; Katz M; Brière J; Jacquillat C; Bernard J
    Bull Cancer; 1981; 68(2):190-9. PubMed ID: 7016225
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Hodgkin's disease.
    Desforges JF; Rutherford CJ
    Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
    [No Abstract]   [Full Text] [Related]  

  • 29. Hodgkin's disease: results of treatment with combination chemotherapy.
    Roeser HP; Roberts SJ; Kynaston B; Whitaker SV; Hocker GA
    Med J Aust; 1977 Dec; 2(25):821-5. PubMed ID: 613196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC
    Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract]   [Full Text] [Related]  

  • 31. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MVPP multiple drug therapy combined with conventional radiotherapy in children with Hodgkin's disease].
    Armata J; Stopyrowa J; Depowski M; Strzeszyński J; Borkowski W; Kaczor Z; Depowska T
    Pediatr Pol; 1978 May; 53(5):571-7. PubMed ID: 683750
    [No Abstract]   [Full Text] [Related]  

  • 33. Towards curative treatment of advanced Hodgkin's disease.
    Falkson HC; Falkson G
    S Afr Med J; 1975 Sep; 49(38):1545-9. PubMed ID: 1179225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
    Hagemeister FB; Fuller LM; Velasquez WS; Sullivan JA; North L; Butler JJ; Johnston DA; Shullenberger CC
    Cancer Treat Rep; 1982 Apr; 66(4):789-98. PubMed ID: 7074649
    [No Abstract]   [Full Text] [Related]  

  • 35. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L; Sciascia R; Baccarani M; Emiliani E; Fiacchini M; Franchini A; Lauria F; Tura S
    Radiol Med; 1978 Feb; 64(2):113-8. PubMed ID: 684251
    [No Abstract]   [Full Text] [Related]  

  • 38. [ Long-term evaluation of the effect of a chemotherapy protocol using vincristine, adriamycin, procarbazine and prednisone (VAPP) on advanced Hodgkin's disease].
    Marinone G; Colle R; Mombelloni P
    Minerva Med; 1978 Apr; 69(18):1255-61. PubMed ID: 662153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Borromeo VD; Wilner FR; Axelrod AR; Schneider JR
    Mich Med; 1975 Sep; 74(27):557-63. PubMed ID: 1160622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.